Streetbeat News

Stock Prices

RMD

ResMed (NYSE:RMD) has outperformed the market over the past 5 years, producing an average annual return of 15.15%. A $100 investment in RMD 5 years ago would be worth $200.67 today.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 7:30 pm

MAR

TOST

Toast Inc (TOST) shares are trading higher by 5.15% after announcing an agreement with Marriott International (MAR) to make its Toast for Hotel Restaurants technology available to food and beverage outlets within Marriott's Select service hotels in the U.S. and Canada.

Portfolio Pulse from Henry Khederian

June 12, 2023 | 7:24 pm

ADSK

FIVN

NICE

SPLK

UI

Software stocks are trading higher as investors anticipate a pause in rate hikes ahead of this week's Fed decision, potentially lifting growth sector sentiment.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 7:20 pm

AUUD

Auddia Inc. (NASDAQ:AUUD) shares surged on high volume after announcing the release of its faidr 3.0 app, which offers ad-free AM/FM, podcasts, and exclusive content. The company plans to launch the app on Android in early Q3 and add faidrRadio in mid-June.

Portfolio Pulse from Ryan Gustafson

June 12, 2023 | 7:19 pm

ORCL

Oracle Corporation (NYSE:ORCL) gapped up about 4% on Monday and is set to report its Q4 financial results after the market close. Analysts expect EPS of $1.58 on revenues of $13.73 billion. Evercore ISI Group and Wolf Research analysts raised their price targets for Oracle to $110 and $130, respectively.

Portfolio Pulse from Melanie Schaffer

June 12, 2023 | 7:17 pm

ACLS

ADI

AMAT

MU

STX

TER

Chip and hardware stocks are trading higher due to increased AI popularity and positive demand outlook. May CPI data anticipation and expectations of no Fed rate hike on Wednesday also contribute to the sector's strength.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 7:16 pm

AUUD

Auddia's shares are trading higher on abnormally-high volume following the announcement of the launch of its faidr 3.0 mobile app.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 7:04 pm

OVV

In the last quarter, Ovintiv (NYSE:OVV) received mostly bullish and indifferent analyst ratings. The company's average 12-month price target is $49.33, a decrease of 15.68% from the previous average of $58.50.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 7:02 pm

VNT

Over the past 3 months, 7 analysts have published their opinions on Vontier (NYSE:VNT) stock, with an average price target of $31.29, slightly below the current price of $31.425. The average price target has increased by 11.19% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 7:01 pm

COGT

In the last quarter, Cogent Biosciences (NASDAQ:COGT) received 7 bullish and 2 somewhat bullish ratings from 9 analysts. The average 12-month price target is $23.44, a 9.85% decrease from the previous average of $26.00.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 7:01 pm